1. Hernández-Charro B er al. Modifying effect of HLA haplotypes located trans to DQB1*02-DRB1*03 in celiac patients of Southern Europe. Tissue Antigens. 2008 71(3):213-8.
  2. Husby S et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012; 54(1):136-60.
  3. Karell K et al.  HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol. 2003; 64(4):469-77.
  4. Margaritte-Jeannin P et al. HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease. Tissue Antigens. 2004; 63(6):562-7.
  5. Megiorni F & Pizzuti A. HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing. J Biomed Sci. 2012; 11;19:88.
  6. Sollid L et al. Evidence for a primary association of celiac disease to a particular HLADQ-alpha/beta heterodimer. J.Exp.Med. 2003; 169: 345 – 350.
  7. Tollefsen S et al.  HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest. 2006; 116(8):2226-36.
  8. Trabace S et al.  HLA-ABC and DR antigens in celiac disease. A study in a pediatric Italian population. Vox Sang. 1984;46(2):102-6.
  9. van Belzen MJ et al.  Defining the contribution of the HLA region to cis DQ2-positive coeliac disease patients. Genes Immun. 2004 5(3):215-20.
  10. van Heel DA et al. Genetics in coeliac disease. Best Pract Res Clin Gastroenterol. 2005; 19(3):323-39. Review.